97 related articles for article (PubMed ID: 7216170)
1. [Synthetic tripeptides as chemotaxins or chemotaxin antagonists (author's transl)].
Fruchtmann R; Kreisfeld K; Marowski C; Opitz W
Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):163-74. PubMed ID: 7216170
[TBL] [Abstract][Full Text] [Related]
2. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
Opitz W; Fruchtmann R
Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
[TBL] [Abstract][Full Text] [Related]
3. Formyl peptide chemoattractants. Synthesis and chemotactic activity.
Falcomer C; Vertuani G; Boggian M; Scatturin A; Spisani S; Cavalletti T; Traniello S
Farmaco Sci; 1987 Nov; 42(11):815-22. PubMed ID: 3443176
[TBL] [Abstract][Full Text] [Related]
4. The effect of the cyclopropyl group on the conformation of chemotactic formyl tripeptides.
Headley AD; Ganesan R; Nam J
Bioorg Chem; 2003 Apr; 31(2):99-108. PubMed ID: 12729567
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of oligotuftsin-based branched oligopeptide conjugates for chemotactic drug targeting.
Mezö G; Láng O; Jakab A; Bai KB; Szabó I; Schlosser G; Láng J; Köhidai L; Hudecz F
J Pept Sci; 2006 May; 12(5):328-36. PubMed ID: 16245264
[TBL] [Abstract][Full Text] [Related]
6. The role of (Z)-2,3-didehydrophenylalanine and phenylalanine C-terminal residues in determining the chemotactic activity of formylpeptides.
Torrini I; Zecchini GP; Paradisi MP; Spisani S
Arch Pharm (Weinheim); 1996 Mar; 329(3):143-8. PubMed ID: 9005813
[TBL] [Abstract][Full Text] [Related]
7. Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe.
Torrini I; Zecchini GP; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S; Cerichelli G
Biopolymers; 1994 Oct; 34(10):1291-302. PubMed ID: 7948717
[TBL] [Abstract][Full Text] [Related]
8. A multifunctional receptor on the neutrophil for synthetic chemotactic oligopeptides.
Becker EL
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):701-9. PubMed ID: 392088
[No Abstract] [Full Text] [Related]
9. Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline.
Haddox JL; Pfister RR; Muccio DD; Villain M; Sommers CI; Chaddha M; Anantharamaiah GM; Brouillette WJ; DeLucas LJ
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2427-9. PubMed ID: 10476813
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
[No Abstract] [Full Text] [Related]
11. Synthetic homo-oligomethionine chemoattractants. Conformation-activity study.
Bismara C; Bonora GM; Toniolo C; Becker EL; Freer RJ
Int J Pept Protein Res; 1985 Nov; 26(5):482-92. PubMed ID: 4086165
[TBL] [Abstract][Full Text] [Related]
12. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic factors for bovine leukocytes.
Carroll EJ; Mueller R; Panico L
Am J Vet Res; 1982 Sep; 43(9):1661-4. PubMed ID: 6816108
[TBL] [Abstract][Full Text] [Related]
14. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a. Transient conversion into an active co-chemotaxin by neutrophils.
Kew RR; Fisher JA; Webster RO
J Immunol; 1995 Dec; 155(11):5369-74. PubMed ID: 7594552
[TBL] [Abstract][Full Text] [Related]
15. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Dahinden C; Fehr J
J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase synthesis of chemotactic peptides using alpha-azido acids.
Tornøe CW; Sengeløv H; Meldal M
J Pept Sci; 2000 Jul; 6(7):314-20. PubMed ID: 10946996
[TBL] [Abstract][Full Text] [Related]
17. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
Lucente G; Giordano C; Sansone A; Torino D; Spisani S
Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic requirements of bovine leukocytes.
Gray GD; Knight KA; Nelson RD; Herron MJ
Am J Vet Res; 1982 May; 43(5):757-9. PubMed ID: 6283962
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S
Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
